Expert Scientists and Clinicians
Our Scientific Advisors
We’ve engaged a prestigious Scientific Advisory Board with expertise in autoimmune and inflammatory diseases, who conduct research in DYRK1A, STING and other related pathways, to provide critical assessment of our bold research plans and judicious advice on strategic approaches for robust and efficient development of our novel pipeline.
Kate Fitzgerald, PhD
Member


Kate Fitzgerald, PhD
Member
Bernard Khor, MD, PhD
Member


Bernard Khor, MD, PhD
Member
Pui Lee, MD, PhD
Member


Pui Lee, MD, PhD
Member
Peter A Nigrovic, MD
Member


Peter A Nigrovic, MD
Member
Bridget Wagner, PhD
Member

